- Home
- CRNX vs ROMA Comparison
CRNX vs ROMA Comparison
Compare CRNX & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ROMA
- Stock Information
- Founded
- CRNX 2008
- ROMA 2018
- Country
- CRNX United States
- ROMA Hong Kong
- Employees
- CRNX N/A
- ROMA N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ROMA Savings Institutions
- Sector
- CRNX Health Care
- ROMA Finance
- Exchange
- CRNX Nasdaq
- ROMA Nasdaq
- Market Cap
- CRNX 2.8B
- ROMA 150.7M
- IPO Year
- CRNX 2018
- ROMA 2024
- Fundamental
- Price
- CRNX $34.20
- ROMA $3.15
- Analyst Decision
- CRNX Strong Buy
- ROMA
- Analyst Count
- CRNX 7
- ROMA 0
- Target Price
- CRNX $74.33
- ROMA N/A
- AVG Volume (30 Days)
- CRNX 1.1M
- ROMA 50.9K
- Earning Date
- CRNX 11-11-2025
- ROMA 09-25-2025
- Dividend Yield
- CRNX N/A
- ROMA N/A
- EPS Growth
- CRNX N/A
- ROMA N/A
- EPS
- CRNX N/A
- ROMA N/A
- Revenue
- CRNX $1,392,000.00
- ROMA $1,568,345.00
- Revenue This Year
- CRNX $489.51
- ROMA N/A
- Revenue Next Year
- CRNX $661.93
- ROMA N/A
- P/E Ratio
- CRNX N/A
- ROMA N/A
- Revenue Growth
- CRNX 0.51
- ROMA 23.21
- 52 Week Low
- CRNX $24.10
- ROMA $0.54
- 52 Week High
- CRNX $62.53
- ROMA $4.66
- Technical
- Relative Strength Index (RSI)
- CRNX 58.12
- ROMA 56.69
- Support Level
- CRNX $33.42
- ROMA $2.28
- Resistance Level
- CRNX $37.23
- ROMA $3.37
- Average True Range (ATR)
- CRNX 1.48
- ROMA 0.34
- MACD
- CRNX -0.01
- ROMA 0.11
- Stochastic Oscillator
- CRNX 56.59
- ROMA 84.63
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.